Swiss pharmaceutical giant Novartis will pay $28.1 billion for an additional 52 percent stake in Alcon, the worlds largest eye-care company.
The transaction is the second stage of a takeover announced in April 2008 when Novartis purchased from Nestlé S.A. 25 percent of the company for $10.4 billion (NYLJ, April 10, 2008).
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
